Table 4.

Hallmark Pathways enriched in high- and low-risk groups by using GSEA.

ID	NES	p value	p.adjust	FDR
HALLMARK_KRAS_SIGNALING_DN	−1.909	0.001	0.027	0.018
HALLMARK_MYOGENESIS	−2.822	0.001	0.027	0.018
HALLMARK_PANCREAS_BETA_CELLS	1.692	0.004	0.045	0.03
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	−1.55	0.004	0.045	0.03
HALLMARK_MYC_TARGETS_V2	1.722	0.005	0.045	0.03
HALLMARK_SPERMATOGENESIS	2.529	0.009	0.047	0.031
HALLMARK_E2F_TARGETS	4.224	0.012	0.047	0.031
HALLMARK_G2M_CHECKPOINT	3.904	0.012	0.047	0.031
HALLMARK_INTERFERON_GAMMA_RESPONSE	1.679	0.012	0.047	0.031
HALLMARK_MTORC1_SIGNALING	1.524	0.012	0.047	0.031
HALLMARK_MYC_TARGETS_V1	1.971	0.012	0.047	0.031
HALLMARK_MITOTIC_SPINDLE	2.916	0.012	0.047	0.031
HALLMARK_INTERFERON_ALPHA_RESPONSE	1.834	0.012	0.047	0.031
HALLMARK_INFLAMMATORY_RESPONSE	1.268	0.024	0.084	0.055
HALLMARK_ANDROGEN_RESPONSE	1.51	0.025	0.084	0.055
HALLMARK_APICAL_SURFACE	−1.518	0.034	0.105	0.069
HALLMARK_ALLOGRAFT_REJECTION	1.248	0.036	0.105	0.069
HALLMARK_P53_PATHWAY	−1.331	0.044	0.12	0.079
HALLMARK_IL6_JAK_STAT3_SIGNALING	1.396	0.046	0.12	0.079

GSEA, gene set enrichment analysis; NES, normalized enrichment score; FDR, false discovery rate.